141 related articles for article (PubMed ID: 8423715)
21. [Functional imaging of the brain using low dose gadolinium-DTPA and Turbo-FLASH sequences].
Hackländer T; Hofer M; Paselk C; Mödder U
Rofo; 1993 Apr; 158(4):348-54. PubMed ID: 8477076
[TBL] [Abstract][Full Text] [Related]
22. The effects of paramagnetic contrast agents on metabolite protons in aqueous solution.
Murphy PS; Leach MO; Rowland IJ
Phys Med Biol; 2002 Mar; 47(6):N53-9. PubMed ID: 11936183
[TBL] [Abstract][Full Text] [Related]
23. Nuclear magnetic relaxation dispersion profiles of aqueous solutions of a series of Gd(NOTA) analogs.
Geraldes CF; Brown RD; Brucher E; Koenig SH; Sherry AD; Spiller M
Magn Reson Med; 1992 Oct; 27(2):284-95. PubMed ID: 1334203
[TBL] [Abstract][Full Text] [Related]
24. Stability assessment of gadolinium complexes by P-31 and H-1 relaxometry.
Vander Elst L; Van Haverbeke Y; Goudemant JF; Muller RN
Magn Reson Med; 1994 Apr; 31(4):437-44. PubMed ID: 8208120
[TBL] [Abstract][Full Text] [Related]
25. Lanthanide-EDTA doped agarose gels for use in NMR imaging phantoms.
Waiter GD; Foster MA
Magn Reson Imaging; 1997; 15(8):929-38. PubMed ID: 9322212
[TBL] [Abstract][Full Text] [Related]
26. Enhancement effects and relaxivities of gadolinium-DTPA at 1.5 versus 3 Tesla: a phantom study.
Sasaki M; Shibata E; Kanbara Y; Ehara S
Magn Reson Med Sci; 2005; 4(3):145-9. PubMed ID: 16462135
[TBL] [Abstract][Full Text] [Related]
27. From the relaxivity of Gd(DTPA)2- to everything else.
Koenig SH
Magn Reson Med; 1991 Dec; 22(2):183-90. PubMed ID: 1812344
[TBL] [Abstract][Full Text] [Related]
28. Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide.
Tanimoto A; Pouliquen D; Kreft BP; Stark DD
J Magn Reson Imaging; 1994; 4(5):653-7. PubMed ID: 7526912
[TBL] [Abstract][Full Text] [Related]
29. Factors determining the proton T1 relaxivity in solutions containing Gd-DTPA.
Aime S; Nano R
Invest Radiol; 1988 Sep; 23 Suppl 1():S264-6. PubMed ID: 3198359
[TBL] [Abstract][Full Text] [Related]
30. Proton relaxation enhancement of albumin, immunoglobulin G, and fibrinogen labeled with Gd-DTPA.
Paajanen H; Reisto T; Hemmilä I; Komu M; Niemi P; Kormano M
Magn Reson Med; 1990 Jan; 13(1):38-43. PubMed ID: 2319934
[TBL] [Abstract][Full Text] [Related]
31. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
[TBL] [Abstract][Full Text] [Related]
32. In vitro study of relationship between signal intensity and gadolinium-DTPA concentration at high magnetic field strength.
Shahbazi-Gahrouei D; Williams M; Allen BJ
Australas Radiol; 2001 Aug; 45(3):298-304. PubMed ID: 11531752
[TBL] [Abstract][Full Text] [Related]
33. In Vitro Longitudinal Relaxivity Profile of Gd(ABE-DTTA), an Investigational Magnetic Resonance Imaging Contrast Agent.
Varga-Szemes A; Kiss P; Rab A; Suranyi P; Lenkey Z; Simor T; Bryant RG; Elgavish GA
PLoS One; 2016; 11(2):e0149260. PubMed ID: 26872055
[TBL] [Abstract][Full Text] [Related]
34. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
[TBL] [Abstract][Full Text] [Related]
35. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
Burai L; Tóth E; Sour A; Merbach AE
Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
[TBL] [Abstract][Full Text] [Related]
36. Multinuclear MR characterization of a new hepatobiliary contrast agent. Preliminary results.
Vander Elst L; Maton F; Laurent S; Seghi F; Muller RN
Acta Radiol Suppl; 1997; 412():135-8. PubMed ID: 9240092
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of gadoteric acid for delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) at the wrist and knee and comparison with Gd-DTPA.
Rehnitz C; Klaan B; Do T; Barié A; Kauczor HU; Weber MA
J Magn Reson Imaging; 2017 Nov; 46(5):1433-1440. PubMed ID: 28263424
[TBL] [Abstract][Full Text] [Related]
38. Parameter optimization and calibration of 19F magnetic resonance imaging at 1.5 Tesla.
Gong BZ; Gill M; Washburn DB; Davenport WC; Adams D; Kwock L
Magn Reson Imaging; 1991; 9(1):101-6. PubMed ID: 2056847
[TBL] [Abstract][Full Text] [Related]
39. Concentration of gadolinium-diethylene triamine pentaacetic acid in human kidney--study on proper time for dynamic magnetic resonance imaging of the human kidney on low and high magnetic fields.
Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T; Tanikawa T; Sato S
Tohoku J Exp Med; 1993 Oct; 171(2):119-28. PubMed ID: 8128480
[TBL] [Abstract][Full Text] [Related]
40. Improvement of brain lesion detection at 0.1 T by simultaneous use of Gd-DTPA and magnetization transfer imaging.
Ramadan UA; Aronen HJ; Tanttu JI; Karjalainen PT; Kairemo KJ; Jääskeläinen J; Sipilä L; Häkkinen AM
Magn Reson Med; 1997 Feb; 37(2):268-74. PubMed ID: 9001152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
